| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |